Semaglutide medications including Ozempic and Wegovy have been shown to reduce kidney failure risk and the risk of death among people with kidney disease and type 2 diabetes. Two doctors weighed in.

"Historically, kidney-related research has been inexcusably underfunded compared to other disease states," researchers wrote, emphasizing the need for greater investment in new treatments and ...

Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday summarized the revised ...

A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), ...

The national average number of patients who died from a kidney-related disease between 2018 and 2022 was 13.2 per 100,000, according to data from the National Institutes of Health.

Novo Nordisk's Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the Danish drugmaker published on Saturday.

A 45-year-old woman was evaluated in the rheumatology clinic because of possible IgG4-related disease. She had polyclonal hypergammaglobulinemia, as well as kidney and bone lesions. A diagnosis was ...

According to the Centers for Disease Control and Prevention, Florida ranks third in the United States for kidney disease-related deaths. Stay up-to-date: The latest headlines and weather from WPBF 25 ...

Gene related to human kidney disease linked to touch in sea anemones New study improves understanding of the ancestral foundations and evolution of mechanosensory cells critical to the success of ...